HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WVE Declares Summer’s Eve Victory, Still Calling For ‘Radical Transformation’ Of Fem Care

Executive Summary

After years of campaigning, Women’s Voices for the Earth is pleased by Summer’s Eve’s apparent reformulation of feminine cleaning products to remove ingredients of concern. But the NGO’s larger complaint pertains to the overall intimate-care category and its marketing.

You may also be interested in...



CIR ‘Watchdog’ Women’s Voices For The Earth To Remain On Guard In 2021

NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.

FDA Denies WVE Petition For Feminine Wash Colorant Guidance

FDA doesn’t see a need for the guidance requested by Women’s Voices for the Earth, but that doesn’t mean the NGO’s point was entirely lost on the agency. Feminine washes continue to contain colorants permitted for external use only – a seeming paradox, particularly in light of pH balance claims.

Prestige Brands Extends Summer’s Eve Line On Ingredient Concerns

Summer’s Eve helped drive the firm’s net sales up 3% to $257m in Prestige Brand’s latest quarter, but it also drove analysts’ questions on whether the brand will sustain growth despite health care advocates’ concerns about potential harmful effects from some ingredients common in feminine wipe products.

Topics

UsernamePublicRestriction

Register

RS151106

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel